BioSpace News Archive

OncoMyx Therapeutics , a privately-held oncolytic immunotherapy company, announced that members of its senior management team will provide a company update today at 2:30 pm ET and host investor meetings at the Chardan Virtual 4th Annual Genetic Medicines Conference. The conference is taking place virtually October 5 th and 6 th . “We are leveraging the unique advantages of myxoma virus to target mechanisms that are common

Eureka Therapeutics Announces Initiation of ARYA-1 Clinical Trial to Evaluate ET140203 ARTEMIS ® T Cell Therapy in Hepatocellular Carcinoma

Horizon Therapeutics plc Announces TEPEZZA ® (teprotumumab-trbw) Selected as a Winner of the R&D 100 Award DUBLIN--( BUSINESS WIRE )-- Horizon Therapeutics plc (Nasdaq: HZNP) today announced that TEPEZZA ® (teprotumumab-trbw) was selected as a 2020 R&D World R&D 100 Award recipient in the Process/Prototyping category. TEPEZZA is the first and only medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of Thyroid E

Verto Health, a leader in connection and communication software for the healthcare industry, today announced the launch of its COVID-19 Appointment Booking and Assessment Centre Capacity Optimization Solution for hospital health systems, which can be implemented and made live within 48 hours.

Masimo (NASDAQ: MASI) today announced the launch of the Radius Tº™ Continuous Thermometer for consumers. Unlike spot-check, episodic thermometers, the wearable, wireless Radius Tº measures body temperature continuously, seamlessly transmitting data and customizable temperature notifications to the user’s smartphone – helping ca

Aytu BioScience, Inc. (NASDAQ:AYTU) announced today that the Company will present its operational results for the fiscal fourth quarter and year ended June 30, 2020 on October 6, 2020, at 4:30 p.m. ET.

- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, joins the PFIC Advocacy and Resource Network (PFIC Network) in recognition of PFIC Awareness Day 2020, a global effort to support patients and families affected by progressive familial intrahepatic cholestasis (PFIC). PFIC is a rare genetic disorder that causes progressive, life-threatening liver disease characterized by a

Medicure Inc. (“Medicure” or the “Company”) (TSXV: MPH) (OTC: MCUJF), a pharmaceutical company, announces that through its wholly-owned subsidiary, Medicure International Inc., it has entered into a License, Manufacture and Supply Agreement (the “Agreement”) with Reliance Life Sciences Private Limited (&qu

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will host an investor and analyst webinar on Wednesday, Oct. 14, 2020 , at 1:00 pm ET , with a panel of leading dental experts to discuss the advantage

- Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com - [05-October-2020] MISSISSAUGA, Ontario , Oct. 5, 2020 /PRNewswire/ -- Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF), a Canadian focused healthcare company with global rea